Single-dose of Nalmefene to Modulate Neural Alcohol Cue Reactivity

NCT02372318 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
TERMINATED
Status
23
Enrollment
OTHER
Sponsor class

Stopped Anticipated nr of 25 probands was not reached in terms of full data sets (missing data, low fMRI data quality), but time frame for recruitment ended.

Conditions

Interventions

Sponsor

Central Institute of Mental Health, Mannheim

Collaborators